Biogen Idec names Cambridge BioMarketing agency of record

Published on .

Boston—Biogen Idec has selected Cambridge BioMarketing as its first agency of record following a review.

Cambridge BioMarketing will develop brand strategy and marketing for the launch of Biogen Idec’s lumiliximab product. The launch campaign will include print, digital, direct and collateral. The budget was undisclosed.

Most Popular
In this article: